Sagility promoter sells 12% stake for Rs 2,395 crore; Smallcap World Fund raises holding in Lotus Developers

According to bulk-deal data, Sagility B V sold 56 crore equity shares, representing 11.96% of the company's paid-up equity capital. The transaction was valued at Rs 2,394.56 crore. Sagility is a technology-enabled healthcare solutions and services provider focused on US health insurance companies. The shares were sold at an average price of Rs 42.76 apiece. According to the latest shareholding pattern, Sagility B V held a 50.95% stake in the company.

On the other side, six domestic and global institutional investors collectively acquired a 5.19% stake in Sagility, worth Rs 1,039.32 crore. BNP Paribas Financial Markets purchased 5.6 crore equity shares for Rs 240.19 crore, while Societe Generale acquired 4.75 crore shares for Rs 203.09 crore. Ghisallo Master Fund LP bought 4.45 crore shares for Rs 190.51 crore. Meanwhile, ICICI Prudential Life Insurance Company acquired 3.25 crore shares for Rs 139.31 crore, and ICICI Prudential Mutual Fund purchased 3.5 crore shares for Rs 150 crore.

Both transactions were executed at Rs 42.75 per share. Goldman Sachs Funds also acquired 2.72 crore Sagility shares for Rs 116.21 crore at an average price of Rs 42.62 per share. Smallcap World Fund raises stake in Sri Lotus Developers and Realty Meanwhile, US-based Smallcap World Fund, managed by Capital Group, acquired an additional 1.41 crore equity shares, representing 2.89% of the paid-up equity capital, in Mumbai-based Sri Lotus Developers and Realty for Rs 339.36 crore.

The shares were purchased at an average price of Rs 240 apiece. According to the latest shareholding pattern, the fund held a 1.95% stake, equivalent to 95.05 lakh shares, in the company. SBI Life Insurance increases stake in Strides Pharma Science SBI Life Insurance Company increased its shareholding in Strides Pharma Science through an open-market transaction on Friday. The insurer held a 3.47% stake in the pharmaceutical company as of September 2026.

SBI Life acquired 6.62 lakh shares, equivalent to 0.71% of the paid-up equity capital, for Rs 69.23 crore at an average price of Rs 1,045.28 per share. Despite the transaction, Strides Pharma Science shares declined 2.62% to close at Rs 1,068.80, recovering significantly from the day's low of Rs 972.